PHARMACEUTICAL COMPOSITION FOR USE IN THE PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF L-DOPA-INDUCED DYSKINESIA

Patent number:

US11337985B2

Galicia.svg
No items found.

Pharmaceutical composition for use in the prophylactic and/or therapeutic treatment of dyskinesias induced by L-DOPA. The present invention relates to the pharmaceutical field, more particularly to the use of Rho kinase inhibitors for treating or preventing dyskinesias induced by L-DOPA.

Countries:
Spain
Regions:
Galicia
Centers:
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

The results that are presented in this document demonstrate that inhibition of the RhoA/Rho kinase (ROCK) pathway makes it possible to treat and/or prevent the dyskinesias that may be caused by chronic treatment with L-DOPA, administered to patients with Parkinson's disease.

Comments

Other related patents

Health

Method for the exploration of obstructive sleep apnea based on the oxygen saturation signal 

Countries
Spain
Know more
Health

Device and procedure for hearing protection

Countries
Spain
Know more
Health

MOLD FOR THE MANUFACTURE OF ARTICULATION IMPELLERS AND PATTERSON TRACKS

Countries
Spain
Know more
Get back to patents directory